The current system of innovation is expensive and cumbersome. The development ecosystem is stifled by bureaucracy, cost, and fragmentation.

The result:
Disease has become a revenue stream. We’re here to change that.

We support the discovery and analysis of key biomarkers and measurable signals in the body that can reveal cancer earlier, faster, and more accurately. By advancing diagnostic tools and detection strategies, we aim to enable access to tools, identify and treat cancer sooner thus, improving survival rates, and reducing the burden on patients and families.

We focus on moving cancer diagnoses from late-stage to early-stage where treatment is more effective, survival rates are higher, and costs are lower. By supporting innovations in screening, diagnostics, and community access, we aim to shift the timeline of care and give patients a better chance at recovery from the start.

We’re working to increase access, volume, and visibility of clinical trials across Arizona, connecting patients with cutting-edge treatments and accelerating innovation. By strengthening infrastructure and partnerships, we aim to make Arizona a national leader in trial participation, helping more people benefit from life-saving research.

We help accelerate the creation and delivery of new cancer therapies by supporting pharmaceutical innovation in Arizona. Through strategic partnerships, infrastructure development, and funding pathways, we aim to reduce barriers for drug developers and bring promising treatments to patients faster and turning research into real-world impact.

We champion policies that remove barriers to cancer care from cost and coverage to education and early detection. By engaging with state and federal leaders, we advocate for smarter incentives, streamlined approvals, and preventative strategies that prioritize outcomes over bureaucracy. Our goal: a system where every patient has a fair chance at survival.